Magellan Health, Inc. (NASDAQ: MGLN) Stock Competitors & Peer Comparison
See MGLN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MGLN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MGLN | $94.99 | N/A | 0 | 8.49 | $11.19 | N/A |
| UNH | $405.08 | -0.90% | 365.3B | 24.61 | $16.34 | +2.22% |
| CVS | $94.25 | -1.48% | 119.3B | 11.93 | $7.84 | +2.85% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $395.39 | -0.58% | 84.7B | 13.28 | $29.39 | +1.76% |
| CI | $275.17 | -1.16% | 72.4B | 8.86 | $30.90 | +2.26% |
| HUM | $388.00 | +0.60% | 44.8B | 23.52 | $15.86 | +0.94% |
| CNC | $66.83 | +0.39% | 32B | 25.74 | $2.52 | N/A |
| MOH | $203.10 | +2.14% | 10.2B | 28.10 | $6.92 | N/A |
| OSCR | $28.87 | +4.32% | 7.2B | 19.97 | $1.40 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
MGLN vs UNH Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, UNH has a market cap of 365.3B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while UNH trades at $405.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas UNH's P/E ratio is 24.61. In terms of profitability, MGLN's ROE is +0.00%, compared to UNH's ROE of +0.14%. Regarding short-term risk, MGLN is less volatile compared to UNH. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
MGLN vs CVS Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, CVS has a market cap of 119.3B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while CVS trades at $94.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CVS's P/E ratio is 11.93. In terms of profitability, MGLN's ROE is +0.00%, compared to CVS's ROE of +0.06%. Regarding short-term risk, MGLN is less volatile compared to CVS. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
MGLN vs ANTM Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas ANTM's P/E ratio is 18.99. In terms of profitability, MGLN's ROE is +0.00%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, MGLN is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
MGLN vs ELV Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, ELV has a market cap of 84.7B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while ELV trades at $395.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas ELV's P/E ratio is 13.28. In terms of profitability, MGLN's ROE is +0.00%, compared to ELV's ROE of +0.11%. Regarding short-term risk, MGLN is less volatile compared to ELV. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check ELV's competition here
Cigna Corporation (NYSE: CI)
MGLN vs CI Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, CI has a market cap of 72.4B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while CI trades at $275.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CI's P/E ratio is 8.86. In terms of profitability, MGLN's ROE is +0.00%, compared to CI's ROE of +0.15%. Regarding short-term risk, MGLN is less volatile compared to CI. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check CI's competition here
Humana Inc. (NYSE: HUM)
MGLN vs HUM Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, HUM has a market cap of 44.8B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while HUM trades at $388.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas HUM's P/E ratio is 23.52. In terms of profitability, MGLN's ROE is +0.00%, compared to HUM's ROE of +0.07%. Regarding short-term risk, MGLN is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check HUM's competition here
Centene Corp. (NYSE: CNC)
MGLN vs CNC Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, CNC has a market cap of 32B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while CNC trades at $66.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CNC's P/E ratio is 25.74. In terms of profitability, MGLN's ROE is +0.00%, compared to CNC's ROE of -0.24%. Regarding short-term risk, MGLN is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
MGLN vs MOH Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, MOH has a market cap of 10.2B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while MOH trades at $203.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas MOH's P/E ratio is 28.10. In terms of profitability, MGLN's ROE is +0.00%, compared to MOH's ROE of -0.00%. Regarding short-term risk, MGLN is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
MGLN vs OSCR Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, OSCR has a market cap of 7.2B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while OSCR trades at $28.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas OSCR's P/E ratio is 19.97. In terms of profitability, MGLN's ROE is +0.00%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, MGLN is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
MGLN vs ALHC Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, ALHC has a market cap of 2.7B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while ALHC trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas ALHC's P/E ratio is 146.67. In terms of profitability, MGLN's ROE is +0.00%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, MGLN is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
MGLN vs CLOV Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, CLOV has a market cap of 2.3B. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while CLOV trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CLOV's P/E ratio is 102.95. In terms of profitability, MGLN's ROE is +0.00%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, MGLN is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
MGLN vs BHG Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas BHG's P/E ratio is -0.12. In terms of profitability, MGLN's ROE is +0.00%, compared to BHG's ROE of +0.04%. Regarding short-term risk, MGLN is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
MGLN vs CABR Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, CABR has a market cap of 12.9M. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while CABR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas CABR's P/E ratio is -2.54. In terms of profitability, MGLN's ROE is +0.00%, compared to CABR's ROE of -3.28%. Regarding short-term risk, MGLN is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check CABR's competition here
Aetna Inc. (NYSE: AET)
MGLN vs AET Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, AET has a market cap of 0. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas AET's P/E ratio is 9.57. In terms of profitability, MGLN's ROE is +0.00%, compared to AET's ROE of +0.11%. Regarding short-term risk, MGLN is similarly volatile compared to AET. This indicates similar risk in terms of short-term price fluctuations for MGLN.Check AET's competition here
Triple-S Management Corporation (NYSE: GTS)
MGLN vs GTS Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, GTS has a market cap of 0. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas GTS's P/E ratio is 10.41. In terms of profitability, MGLN's ROE is +0.00%, compared to GTS's ROE of +0.07%. Regarding short-term risk, MGLN is less volatile compared to GTS. This indicates lower risk in terms of short-term price fluctuations for MGLN.Check GTS's competition here
Universal American Corporation (NYSE: UAM)
MGLN vs UAM Comparison August 2026
Magellan Health, Inc. (NASDAQ: MGLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MGLN stands at 0. In comparison, UAM has a market cap of 0. Regarding current trading prices, MGLN is priced at $94.99 on the NASDAQ, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MGLN currently has a P/E ratio of 8.49, whereas UAM's P/E ratio is 1.01. In terms of profitability, MGLN's ROE is +0.00%, compared to UAM's ROE of +0.17%. Regarding short-term risk, MGLN is similarly volatile compared to UAM. This indicates similar risk in terms of short-term price fluctuations for MGLN.Check UAM's competition here